Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SARS-CoV-2-specific immune responses after COVID-19 vaccination in end-stage renal disease patients and kidney transplant recipients
TCTR20210226002Completed
- Sponsor
- National Research Council of Thailand
- Start
- Apr 2021
- Countries
- 1
01
Overview
Open-label trial in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by National Research Council of Thailand. Primary endpoint: SARS-CoV-2-specific immune response. Started Apr 2021; status: completed.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on TCTR20210226002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210226002.